Log In
Print
BCIQ
Print
Print this Print this
 

Lexiscan, Rapiscan, regadenoson (CVT-3146)

  Manage Alerts
Collapse Summary General Information
Company Gilead Sciences Inc.
DescriptionShort-acting adenosine A2A receptor (ADORA2A) agonist
Molecular Target Adenosine A2A receptor (ADORA2A)
Mechanism of ActionAdenosine A2A receptor agonist; Diagnostic
Latest Stage of DevelopmentMarketed
IndicationCardiovascular, Diagnostic
Partner

Astellas Pharma Inc.


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today